Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Clinical Toxicology (Philadelphia, Pa.)|October 6, 2020
Toxicoepidemiology and predictors of death in 2,4-dinitrophenol (DNP) toxicityA J Potts, N J Bowman, D L Seger, et al.
Scottish Medical Journal|August 1, 1990
Wilson's disease presenting as acute fulminant hepatic failureJ G O'Donnell, I D Watson, G S Fell, et al.
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2010
Electrocardiographic effects of methylphenidate overdoseS L Hill, R H El-Khayat, E A Sandilands, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphomaN L Gilchrist, J Caldwell, I D Watson, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral dosesI S M Salih, R H K Thanacoody, G A McKay, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 8, 2014
Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance studyH J Dunstan, A C Mill, S Stephens, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 4, 2002
Thioridazine and sudden unexplained death in psychiatric in-patientsJ G Reilly, S A Ayis, I N Ferrier, et al.
Annals of Clinical Biochemistry|July 1, 1994
External quality assessment of techniques for the detection of drugs of abuse in urineJ F Wilson, B L Smith, P A Toseland, et al.
Clinical Pharmacology and Therapeutics|April 27, 2007
Factors affecting drug concentrations and QT interval during thioridazine therapyR H K Thanacoody, A K Daly, J G Reilly, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 15, 2019
Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort studyJ L Richardson, F Martin, H Dunstan, et al.
Pageof 7